Latest
“Transformative” grant to push research forward
Related articles:
Beating a Main Cause of Death from Blood or Marrow Transplant
John Hallberg | As a non-scientist, it is a thrill for me to work with some of the brightest cancer researchers and clinicians in the… Read More
Improving therapies for brain tumors
Malignant brain tumors are very difficult to treat and are almost always fatal. New drugs have been developed that specifically target proteins that lead to… Read More
Understanding Myelodysplastic syndrome
What is MDS? Myelodysplastic syndrome (MDS) is a blood cancer in which the bone marrow produces ineffective red cells which carry oxygen, white blood… Read More
Researchers at the University of Minnesota have landed an unprecedented, five-year, $51 million grant from the National Institutes of Health. Bruce Blazar, M.D., who heads the U of M’s Clinical and Translational Science Institute, described the grant as “transformative” in advancing medicine.
The funding will enable researchers to share data and information across many disciplines and research institutions, allowing organizations to solve problems more efficiently. Perhaps most important to cancer research is the focus on creating universal systems to carry out clinical trials, including standardization across hospitals and collaborating with patient safety and oversight boards.
You may also be interested in:
Owen’s Story: Surviving Acute Myeloid Leukemia (AML)
In 2006, when Owen developed an ear infection and a cough at 11 months old, everyone thought a trip to Urgent Care for an antibiotic… Read More
Group Or Corporate Giving
Companies such as Macy's, Delta Air Lines, Thrivent Financial for Lutherans and Hubbard Broadcasting, have long been involved in helping Children’s Cancer Research Fund work… Read More